AstraZeneca plc (ADR) (AZN)
$44.98
0.05 (+0.11%)
| CAPS Rating |
|
|---|---|
| Open | $44.28 |
| Previous Close | $44.93 |
| Daily Range | $44.25 - $45.02 |
| 52-Week Range | $29.96 - $47.61 |
| Market Cap | $65.13B |
| P/E Ratio | 10.70 |
| Dividend (Yield) | 2.09 (4.70%) |
| Volume | 2,044,950 |
| Average Daily Volume | 1,558,000 |
AZN
VS S&P 500 (SPY)
How do you think AZN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
AZN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
AZN News and Commentary
- A Little Distracted, Are You, Merck? – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- This Stable Stock Could Still Surprise – The Motley Fool
- Of One-Time Gains and Pipelines – The Motley Fool
- Eli Lilly stock: Hurt by patent loss – CNN Money
- I Don't Need No Massive Merger – The Motley Fool
- Nibbles Here and There at Forest Labs – The Motley Fool
- Double-Digit Growth in a Recession – The Motley Fool
- 5-Star Stocks Poised to Pop: Novartis – The Motley Fool
- This Partnership Will Go No Further – The Motley Fool
- 5-Star Stocks Poised to Pop: KV Pharmaceutical – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- H1N1 flu taking off in U.S., officials say – Reuters
- UPDATE 1-U.S. flu vaccination off to slow start, CDC says – Reuters
- US flu vaccination off to slow start, CDC says – Reuters
- H1N1 - AZN, NVS or GSK? – Blog at The Motley Fool
- Warning: Potential Blockbuster Ahead – The Motley Fool
- Here We Go Again With Possible Side Effects – The Motley Fool
- My current favorite sector...health care – Blog at The Motley Fool
- Nektar Tastes Sweet – The Motley Fool
RSS Headlines
Fool UK
